SLCO1B1*5 Allele is Associated with Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine Care
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SLCO1B1*5
Allele is Associated with Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine Care
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-01-16
DOI
10.1002/cpt.2527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions
- (2021) Patrick Wu et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Persistent COUP-TFII expression underlies the myopathy and impaired muscle regeneration observed in resistance to thyroid hormone-alpha
- (2021) Paola Aguiari et al. Scientific Reports
- Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing
- (2021) Julio D. Duarte et al. GENETICS IN MEDICINE
- Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
- (2019) Connie B. Newman et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Adherence to Statin Therapy Among US Adults Between 2007 and 2014
- (2019) Lisandro D. Colantonio et al. Journal of the American Heart Association
- Implementation of wide-scale pharmacogenetic testing in primary care
- (2019) Natasha Petry et al. PHARMACOGENOMICS
- Prediction of pharmacokinetic drug-drug interactions causing atorvastatin-induced rhabdomyolysis using physiologically based pharmacokinetic modelling
- (2019) Size Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Peter W.F. Wilson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clinical Pharmacist Patient-Safety Initiative to Reduce Against-Label Prescribing of Statins With Cyclosporine
- (2016) Donald G. Lamprecht et al. ANNALS OF PHARMACOTHERAPY
- Hepatotoxicity of statins and other lipid-lowering agents
- (2016) Einar S. Björnsson LIVER INTERNATIONAL
- Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature
- (2016) Alessandro Sindoni et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Integration of Genomics in Primary Care
- (2015) Eric A. Larson et al. AMERICAN JOURNAL OF MEDICINE
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Underutilization of High-Intensity Statin Therapy After Hospitalization for Coronary Heart Disease
- (2015) Robert S. Rosenson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Statin Underuse and Low Prevalence of LDL-C Control Among U.S. Adults at High Risk of Coronary Heart Disease
- (2014) Christopher M. Gamboa et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 and Simvastatin-Induced Myopathy: 2014 Update
- (2014) L B Ramsey et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Meta-analysis of side effects of statins shows need for trial transparency
- (2014) B. Goldacre BMJ-British Medical Journal
- Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy
- (2013) Jacqueline S. Danik et al. AMERICAN HEART JOURNAL
- The Clinical Pharmacogenomics Implementation Consortium: CPIC Guideline for SLCO1B1 and Simvastatin-Induced Myopathy
- (2012) R A Wilke et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users
- (2012) Jerome D. Cohen et al. Journal of Clinical Lipidology
- Variants Near FOXE1 Are Associated with Hypothyroidism and Other Thyroid Conditions: Using Electronic Medical Records for Genome- and Phenome-wide Studies
- (2011) Joshua C. Denny et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Transporter Pharmacogenetics and Statin Toxicity
- (2009) M Niemi CLINICAL PHARMACOLOGY & THERAPEUTICS
- The SLCO1B1*5Genetic Variant Is Associated With Statin-Induced Side Effects
- (2009) Deepak Voora et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SLCO1B1Variants and Statin-Induced Myopathy — A Genomewide Study
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now